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Abstract.  In vitro studies have shown that keratino- 
cyte growth factor (KGE also known as FGF-7) is 
secreted by fibroblasts and is mitogenic specifically for 
epithelial cells. Therefore, KGF may be an important 
paracrine mediator of epithelial cell proliferation in 
vivo. Because stromal cells are thought to influence 
glandular proliferation in the primate endometrium, 
we investigated the hormonal regulation and cellular 
localization of KGF mRNA expression in the rhesus 
monkey uterus. Tissues were obtained both from natu- 
rally cycling monkeys in the follicular and luteal 
phases of the cycle, and from spayed monkeys that 
were either untreated or treated with estradiol (F_a) 
alone, F_a followed by progesterone (P), F_a plus P, or 
Fa plus P plus an antiprogestin (RU 486).  Northern 
blot analysis of total RNA with 32p-labeled probes re- 
vealed that the level of KGF mRNA in the en- 
dometrium was 70-100-fold greater in the luteal phase 
or after P treatment than in untreated, F_a-treated, or 
follicular phase animals. Northern analysis also 
showed that KGF mRNA was present in the myo- 
metrium but was unaffected by hormonal state. RU 
486 treatment prevented the P-induced elevation of en- 
dometrial KGF mRNA. P-dependent elevation of en- 
dometrial KGF expression was confirmed by measure- 
ment of KGF protein in tissue extracts using a two-site 
enzyme-linked immunosorbent assay.  In situ hybridiza- 
tion with nonradioactive digoxigenin-labeled eDNA 
probes revealed that the KGF mRNA signal, which 
was present only in stromal and smooth muscle cells, 
was substantially increased by P primarily in the 
stromal cells located in the basalis region. Smooth 
muscle cells in the myometrium and the walls of the 
spiral arteries also expressed KGF mRNA, but the de- 
gree of this expression did not differ with hormonal 
state. P treatment led to increased proliferation in the 
glandular epithelium of the basalis region and to ex- 
tensive growth of the spiral arteries. We conclude that 
the P-dependent increase in endometrial KGF resulted 
from a dual action of P:  (a) a P-dependent induction 
of KGF expression in stromal cells, especially those in 
the basalis (zones Ill and IV), and (b) a P-dependent 
increase in the number of KGF-positive vascular 
smooth muscle cells caused by the proliferation of the 
spiral arteries. KGF is one of the first examples in pri- 
mates of a P-induced, stromally derived growth factor 
that might function as a progestomedin. 
M 
ANY reports suggest that the actions of sex steroids 
in target tissues are mediated through locally pro- 
duced growth factors in an autocrine/paracrine 
fashion. For example, EGF (23, 31), insulin-like growth fac- 
tor I (IGF-I) t (15, 30), and TGF-ot (32) are all regarded as 
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1.  Abbreviations  used  in  this paper:  Dig,  Digoxigenin;  E2,  estradiol; 
possible  mediators of the effects of estrogens  on uterine 
growth. Extensive evidence  also exists that stromally derived 
mediators can promote epithelial proliferation and differen- 
tiation  in  steroid  hormone responsive  tissues  (10). Such 
stromal-epithelial interactions  in  adult organs  may be a 
special case of the more general phenomenon of mesenchy- 
real-epithelial interactions that occur during embryonic de- 
velopment (9).  During the menstrual cycle,  the primate 
GAPDH,  glyceraldehyde 3-phosphate dehydrogenase;  GFAP, glial fibril- 
lary  acidic  protein;  IGF,  insulin-like  growth  factor;  KGF, keratinocyte 
growth factor; KGFR, KGF receptor;  oligo-DNA, oligodeoxynucleotides; 
P, progesterone. 
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tissue structure that resemble developmental processes, and 
we have hypothesized  that stromally derived growth factors 
play important roles in such events  (27). 
One candidate for such a stromal mediator is keratinocyte 
growth  factor  (KGF),  which was originally  purified  from 
conditioned medium of human embryonic lung fibrobhsts 
(38). KGF is a unique member of the FGF gene family that 
is mitogenic for a variety of epithelial cell types, but not for 
fibroblasts,  melanocytes,  or  human  sapbenous  vein  en- 
dothelial ceUs (13, 20). KGF mRNA has been detected in a 
variety of tissues (13). Because KGF has a signal peptide se- 
quence and is produced specifically  by cells of mesenchymal 
origin, it could function as a paracrine mediator of epithelial 
ceU proliferation  in vivo during normal growth cycles (13) 
and in wound healing (40, 43). Moreover, there is evidence 
that  KGF  functions  as  an  androgen-dependent  epithelial 
mitogen (an andromedin) in the prostate (reference 45 and 
Rubin, J., D. Peehl, M. Chedid, W. Taylor, D. Run, and S. 
Aaronson, manuscript submitted for publication) and semi- 
hal vesicle (1). In the present studies,  we examined the hor- 
monal regulation and cellular localization of KGF in the rhe- 
sus monkey uterus.  Specifically,  we examined the effects of 
estradiol  (E2) and progesterone  (P) on KGF mRNA expres- 
sion by Northern  blot analysis,  the cellular  distribution  of 
KGF mRNA in the uterus by nonradioactive  in sire hybrid- 
ization (25), and the level of KGF protein by various assays. 
Materials and Methods 
Animals and Tissues 
Uteri and oviducts were obtained from rhesus monkeys (Macaca mulana) 
in the midfollicular (n ffi 2) and midhteal (n = 4) phases of natural ovula- 
tory cycles, as determined by prospective assessment of serum E2 and P 
levels  (5), and from spayed animals that were either untreated (n  =  3), 
treated with E2 alone (14 d of E2; n  =  5),  E2 then P alone (14 d E2, then 
14 d P; n  =  2), E: +  P (14 d E2, then 14 d E2 +  P; n  =  6), or with E2 
+  P  +  RU 486 (14 d E2, then 14 d of E,2 +  P  +  RU 486; n  =  2), where 
RU 486 (1 mg/Iqg) was injected daily intramuscularly in ethanol (39).  Ex- 
cept for RU 486, all hormones were sdministered in Sllastic capsules filled 
with crystalline steroid,  as described previously (44). At the end of each 
treatment, the animals were laparotomized, the uteri were lemoved and dis- 
sected into endometrial and myometrlal  segments,  and the oviducts were 
dissected into flmbrial and ampullary regions. For RNA extraction,  tissues 
were frozen in liquid propane and stored in liquid nitrogen. For in situ hy- 
bridization, tissues were cut into small pieces, embedded in OCT com- 
pound (Tissue Tek, Elkhart, IN), frozen in liquid propane, and then stored 
in liquid nitrogen (25). 
Cells 
M426  human embryonic lung fibroblasts  were  grown in DME  (CAbco 
Laboratories, Grand Island, NY) supplemented with 10%  FBS, 2 mM 
g]utamine, 50 U/m] penicillin, and 50/~g/mi streptomycin  as previously de- 
scribed (38).  B5/589 human maxmnary epithelial cells (41) (a gift of M. 
Stampfer, Univenity of California at Berkeley) were grown in RPMI 1640 
(Gibco Lahoratories), to which 10% FBS, 2 mM ghtamine, 50 U/ml peni- 
cillin, 50/tg/mi streptomycin,  and 4 ng/mi human EGF were added. 
Probes and Labeling 
Human KGF cDNA [0.68 kbp, corresponding to the 5' untranslated region 
and first exon (13, 24)], rhesus glial fibrlllary acidic protein (GFAP) eDNA 
(1.2 kbp) (26) human glyceraldehyde 3-phosphate  dehydrogenase (GAPDH) 
cDNA [PstI-XbeI fragment of cDNA obtained from American Type Cul- 
ture Collection (Rockvllle, MD) (no. 57090) (42)], and linearized pBR 328 
DNA 0B  bringer Mannheim Corp., Indianapolis, IN) were labeled with 
[32p-c~]dCTP (3,000  Ci/mmol,  New  England Nuclear,  Boston, MA) by 
nick translation or random prlmins yielding 2.0-  2.4 x  109 cpm//~g DNA. 
Also, the DNAs were labeled with Digoxigenin-dUTP  (Dig-dUTP) by ran- 
dom priming with a labeling kit (Boehringer Mannheim  Corp.). After etha- 
nol precipitation, the pellet was suspended in 10 mM Tris-HCl buffer (pH 
7.4) containing 1 mM EDTA and 0.1% SDS.  The concentration of Dig- 
labeled probe was expressed  as the amount of template DNA used in the 
labeling ~action.  lmmunohistochemical detection  (25)  of Dig-labeled 
DNA on nylon membranes (Nytran; Schleicher & SchneU, Inc., Keene, 
NH)  revealed  equivalent levels  of Dig-labeling  among these template 
DNAs. 
Sense and antisense strands corresponding to nucleotidas 539-583 of the 
human KGF eDNA sequence (13) were synthesized on a DNA synthesizer 
(Applied Biosystems, Inc., Foster City, CA). These 45-met oligedeoxynu- 
cleotides (oligo-DNAs) were labeled at the T-end with [32P-c~]  ATP (3,000 
Ci/mmol; New England Nuclear) (21) by terminal deoxynucleotidyl  trans- 
ferase (Bochringer Mannheim Corp.). ~2P-labeled oligo-DNAs were sepa- 
rated from unincorporated [32P-cd ATP by Nick Colunm  TM (Pharmacia Fine 
Chemicals, Piscataway, NJ).  The specific activities of these oligo-DNAs 
were 0.6-1.4  ×  109 cpm//zg DNA. 
RNA Preparation and Northern Blot Analysis 
Cell monolayers  were grown in 100-ram culture dishes,  washed in sterile 
PBS,  and iysed in the presence of RNAzul (Tel-Test Inc., Friendswood, 
TX).  Tissues were  pulverized in the presence of liquid nitrogen and 
homogenized in RNAzol.  Total RNA was precipitated with isopropanul 
(50% vol/vol),  washed in 75% ethanol, and resnspended in TE buffer (10 
mM Tris-HC1 [pH 7.4] I mM EDTA). 20-/~g samples of RNA were electro- 
phoresed on 1% formaldehyde ngarose gels and transferred to Nytran nylon 
membranes (sehleicher & Sehnoll,  Inc.). To evaluate the integrity of the 
RNA, gels were stained with ethidium bromide. After cross-llnkins of the 
RNA to the membrane, filters were prehybridized for 2 h and hybridized 
for 20 h at 42°C. When cDNA probes were used, filters were prehybridized 
and hybridized in Hybrisol (Oncor,  Gnithersburg,  MD) (40% formamide, 
10% dextran sulfate,  1% SDS, 6× SSC, and blockin~ agents) and washed 
twice O0 rain each time) at room temperature in 2x SSC, 0.1% SDS, and 
twice at 40°C in 0.5x SSC, 0.1% SDS. When 32P-labeled uligonucleotides 
were used as probes, filters were prehybridized at 42°C for 2 h and hybrid- 
ized for 17-72 h at 42-45°C in a solution containin~ 10 mM Tris-HCl (pH 
7.4),  1 mM ElYrA, 0.6 M NaC1, lx Danhardt's solution, 250/~g/ml yeast 
transfer RNA,  125 ~tg/mi salmon testis DNA,  10% dextran sulfate,  and 
40% formamide.  Membranes were washed in0.Sx SSC, 0.1% SDS at 45°C. 
Filters were exposed  to x-ray  film (Eastman Kodak,  Rochester,  NY) or 
phosphor intensifying screens.  Densitometric analysis was performed with 
a scanner densitometer (Bio-Rad Laboratories, Richmond, CA) or a phos- 
phorimnger (ImngeQuant;  Molecular Dynamics, Inc., Sunnyvale,  CA). 
Measurement of  KGF Protein 
Tissue samples were thawed and homogenized with a Polytron  tissue disrup- 
ter (Brinkmann Instruments, Inc., Westbury, NY) in a solution (2 ml/g wet 
wt) consisting of 1.0 M NaCI, 20 mM Tris-HCl (pH 7.4),  5 mM ED'FA, 
I mM PMSF, 10 ~tg/ml apmtiuin, 10 ~tg/nfl  leupeptin, and 10/~g/ml pepsta- 
tin. After sonication for 30 s  x  3 (power  setting ffi  10; Heat Systems- 
Ultrasonics Inc., Plalnview, NY) and centrifngation at 40,000 g for 30 min 
at 4°C, supernatants were analyzed for KGF using either a radioimmanoas- 
say (4) or a tw~site ELISA. The total protein concentration of the extracts 
was measured (Bio-Rad Laboratories), and all samples were adjusted to a 
uniform concentration before assay (typically concentrations varied ,10% 
before adjustment). For the ELISA, all steps were performed at room tem- 
perature. In brief, 96-well polyvinyl micmtiter plates (no.  3912;  Falcon 
Labware, Oxnard, CA) were precoated with 50/A/weli of a KGF monoclo- 
nul antibody (1G4, 8/~g/ml, (4) overnight and subsequently blocked with 
4% bovine serum albumin_ Serial dilutions of tissue extracts (protein con- 
centrations  Eli mg/ml) were incubated at 50 ~l/well for 5 h; then wells were 
washed extensively  with 0.05 % Tween, 0.02 % sodium azide in PBS, aad 
further incubated overnight with a rabbit pulyclousl antibody (dealsmtted 
no. 9492) raised against recombinant human KGF. After extensive washing 
as above, alkaline phosphatase-conjngated goat anti-rabbit  IsG ('Ihso Inc., 
Burlingmne,  CA) (1:15,000) was a  dd,~_ to the wells. After 2 h, the wells 
were a~ain washed and p-nitrophenyl phosphate (concentration 2 mg/ml) 
was introduced. Optical density was measured at 405 nm with an ELISA 
scanner (Bio-Rad Laboratories). The concentration of the recombinant  hu- 
man KGF standard (37) was based on amino acid analysis and extinction 
coefficient. 
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The procedures  for preparing  frozen sections  (5/~m), attaching  them to 
gelatin-coated slides, fixation, pretreatments,  and hybridization of the sec- 
tions have been described previously (25). Briefly, the slides were fixed in 
4% paraformaldehyde in PBS (pH 7.4) for 20 rain and treated with 0.2 N 
HC1, 0.2 % Triton X-100 in PBS, and proteinase K (1/zg/ml, 37°C, 15 rain), 
successively. Hybridization  was carried out at 37°C overnight in medium 
containing 10 mM Tris-HC1 (pH 7.4), I mM EDTA, 0.6 M NaC1, 1× Den- 
hardt's solution,  250/~g/rul  yeast transfer RNA, 125/~g/ml  salmon testis 
DNA, 10% dextran sulfate, 20 pmol/ml random oligo-DNA (NEP-505; Du 
Pont Pharmaceuticals,  W'dmington, DE), 0.01% SDS, 400 U/ml heparin, 
40%  deionized formamide,  and 0.45-0.5  pg/ml Dig-cDNA. 
After  hybridization,  the  slides  were  washed  three  times  with  2× 
SSC/0.075% Brij 35 (Sigma Chemical Co., St. Louis, MO) at 37°C, twice 
with 0.5  )< SSC/0.075~  Brij 35 at 37°C for 1 h each, and finally washed 
with 0.2 × SSC at 45°C for 30 min. After successive treatments with etha- 
nol  and  acetone  to  dellpidate  the  sections,  the  signals  were  detected 
enzyme-immunohistochemically  with horseradish peroxidase-labeled  anti- 
Dig antibody, as described previously (25). We found in preliminary work 
that delipidation removed nonspecifically bound Dig-cDNA without affect- 
ing specific hybrids. Most of  the above protocol was as previously described 
(25), except for the use of an oligonucleotide mixture (Randomer-36) in the 
hybridization medium and for the delipidafion step after hybridization, both 
of which helped to eliminate nonspecific binding of probe to cell nuclei. 
The staining was observed by either bright field or phase microscopy. Be- 
cause stromal cells have very scanty cytoplasm, phase microscopy was used 
to enhance the hybridization signal. Photomicrographs  of the nonradioac- 
tive in  situ  hybridization  preparations  were  prepared  with  35-ram  film 
(Technical Pan;  Eastman Kodak). 
Controls for In Situ Hybridization 
To evaluate the specificity of KGF mRNA signals, various types of control 
experiments  were  conducted  on adjacent  sections.  As a  conU~l probe, 
GFAP cDNA was used, and some sections were treated with RNase A (100 
#g/ml; 37°C, 1 h) before hybridization. Some sections were hybridized with 
labeled KGF cDNA probes in the presence of  an excess amount of  unlabeled 
KGF cDNA (17-fold) to validate the sequence specificity of the signal. On 
some sections, after hybridization with KGF cDNA, excessively stringent 
washin~ conditions were used. The calculated melting temperature  of the 
KGF cDNA-mRNA hybrids in 50% formamide~.2 × SSC is 22-29°C (24) 
assuming 90-95 % homology in KGF base sequences between monkey and 
human. For an excessively stringent wash, we used the same conditions at 
37°C. 
Identification  of  Proliferating Cells 
A nuclear  antigen associated  with proliferation  was immunohistochemi- 
cally localized  in  frozen  sections  of uteri with  antibody  Ki-67  (DAKO 
PATTS Inc., Santa  Barbara,  CA).  We have described  our immunocyto- 
chemical technique for use of  this antibody in a previous paper on the mon- 
key endometrium (39). Several studies have shown that quantitation of the 
number of cells positively stained  for this antigen in frozen sections pro- 
vides a reliable index of proliferation  (14). 
Histology of  Monkey Uterus 
Glycolmethacrylate  sections of monkey uterus were prepared and stained 
with hematoxylin as described  previously (39). 
Results 
Hormonal Regulation of  KGF mRNA 
in Primate Uterus 
To investigate possible hormonal influences on KGF expres- 
sion  in  the  primate  uterus,  endometrial  and  myometrial 
RNAs were prepared under various treatment conditions. As 
shown in Fig. 1, the 2.4-kb KGF transcript was barely detect- 
able in endometrium of spayed (lane/)  or E2-treated 0ane 
3) monkeys.  However, the KGF mRNA was abundant in the 
Figure  1.  Northern  blot of total  uterine  RNA from hormonally 
treated animals hybridized with 32p-labeled  KGF cDNA. (Lanes 1 
and 2) Spayed animals; endometrium in lane 1 and myometrium in 
lane 2.  (Lanes 3  and 4) E2-treated animals; endometrium in lane 
3  and  myometrinm in  lane 4.  (Lanes  5  and  6)  E2  +  P-treatod 
animals; endometrium in lane 5 and myometrium in lane 6. (Lane 
7) KGF-positive M426  cell line.  (Lane 8) KGF-negative B5/589 
cell line. 2.4 kb marks KGF mRNA, which was markedly enhanced 
by E2  +  P treatment in endometrium, and was present but invari- 
ant in myometrium under all hormonal conditions. The lower por- 
tion of the figure illustrates the signal on these blots after reprobing 
with a  cDNA probe against GAPDH,  confirming that equivalent 
amounts of RNA were loaded and transferred in all lanes. 
endometrium  of animals  treated  with  E2  and  P  (lane 5). 
While  the  transcript  was  detectable  at  low  level  in  myo- 
metrium of spayed animals (lane 2), its level of expression 
was essentially unchanged by E2 or ~  +  P treatment (lanes 
4  and  6).  The  slight  increase  in  signal  from  the  E2  + 
P-treated myometrial sample is probably caused by contami- 
nation with endometrial  tissue. Under the same experimen- 
tal conditions, a typical 2.4-kb band ofKGF mRNA was de- 
tected  in  total  RNA  from  M426  human  fibroblasts,  a 
KGF-positive  line  (lane  7),  but not from B5/589  ceils,  a 
KGF-negative  cell line (lane  8).  The lower portion of the 
figure  illustrates  the  signal  on these  blots  after  reprobing 
with a cDNA probe  against GAPDH,  a housekeeping gene, 
confirming that equivalent amounts of RNA were loaded and 
transferred in all lanes. 
Fig. 2 (lanes 1 and 3) shows that in animals treated sequen- 
tially with E2 followed by P, the degree of endometrial  KGF 
mRNA expression was very high, whether the E2 was con- 
tinued along with the P treatment (E2 +  P; lane/) or the E2 
was stopped and P was administered  alone (E2, P; lane 3). 
In  striking  contrast,  administration  of  RU  486  (lane  2) 
blocked the effect  of P  in upregulating  endometrial  KGF 
mRNA. Fig. 2 also shows that during the natural menstrual 
cycle,  endometrial  KGF  mRNA  expression  was  minimal 
during the follicular  phase (lane 4) and highly abundant in 
the luteal  phase  (lane  5).  The  level  of KGF mRNA was 
equivalent in P-dominated tissues, whether sampled during 
the natural cycle or after hormone administration.  The lower 
portion of the  figure  shows the  signal  obtained  with  the 
GAPDH probe to control  for RNA loading and transfer. 
Fig. 3 A shows that upregulation of KGF mRNA by P was 
tissue specific.  When Northern blots of total RNAs from en- 
dometrium and oviduct of E2- or E2  +  P-treated  monkeys 
were probed  with  32p-labeled KGF antisense  oligo-DNA, 
Koji et al. Progesterone-dependent KGF mRNA Expression  395 Figure  2. Northern blot of  total endometrial RNA from hormonally 
treated and naturally cycling macaques hybridized with 32P-labeled 
KGF cDNA. Hormonal conditions for each lane were as follows: 
Lane 1, E2 +  P combined; lane 2, E2 +  P +  RU 486; lane 3, E2 
followed by P alone (E2, P); lane 4, follicular phase of the men- 
strual cycle; and lane 5, luteal phase of the menstrual cycle. 2.4 kb 
marks KGF mRNA, which was elevated in P-dominated tissues, 
whether E2 was present or absent. This effect of P was suppressed 
by RU 486. The lower portion of the figure illustrates the signal on 
these blots after reprobing with a cDNA probe against GAPDH, 
confirming that equivalent amounts of  RNA were loaded and trans- 
ferred in all lanes as above. 
the 2.4-kb band of KGF mRNA  was  detected in the en- 
dometrial (lane 3), but not the oviductal RNA preparation 
(lanes 1 and 2). Ethidum bromide staining of the agarose gel 
used to prepare the blot in Fig.  3 A indicated that similar 
mounts of RNA were loaded in each lane (Fig. 3 B). All 
of  these results indicated  that KGF mRNA was markedly up- 
regulated in the endometrium but not the myometrium or 
oviduct in response to P. 
Elevated KGF Protein Levels in Endometrium 
after P Treatment 
In an effort to determine whether KGF mRNA expression 
was correlated with the detection of KGF protein, we devel- 
oped a sensitive two-site ELISA as described in Materials 
and Methods. In this assay, recombinant KGF was detectable 
at subnanogram amounts (Fig. 4). In this same assay,  en- 
dometrial tissue  extracts  showed readily detectable KGF- 
immunoreactive material. As illustrated in Fig. 4, the titra- 
tion patterns exhibited by these extracts in the ELISA closely 
matched  that  of the  recombinant human  KGF  standard, 
strongly suggesting that the cross-reactivity resulted from 
endogenous KGF. Moreover, the results summarized in Fig. 
4  and  Table I  demonstrated that endometriai tissue  from 
animals in the luteal phase or treated with F_a  +  P  showed 
more KGF immunoreactivity than tissue from animals in the 
follicular phase  or  exposed only to  E2.  Similar  findings 
were obtained when samples were surveyed in a KGF radio- 
immunoassay  (data  not  shown).  These data  indicate that 
KGF  protein  was  present  in  the  endometrium  and  was 
elevated in P-dominated tissue. 
Cellular Localization of  KGF mRNA in the Uterus 
To examine the cellular localization of KGF transcript in the 
uterus, we performed in situ hybridization. During all hor- 
monal conditions, there was a distinct but essentially invari- 
ant, cytoplasmic signal for KGF mRNA in the smooth mus- 
Figure 3. (A) Northern blot of  oviductal and endometrial total RNA 
hybridized  with  32p-labeled antisense  oligo-DNA.  Tissues and 
hormonal conditions for each lane were as follows:  Lane 1, oviduct, 
treated;  lane  2,  oviduct,  ~  +  P  treated;  and  lane  3,  en- 
dometrium, F_~ +  P treated. 2.4 kb marks KGF transcript that was 
increased by P only in the endometrium, not in the oviduct. (B) 
Ethidium bromide-stained  gel used to produce the blot shown in 
Fig. 3. Essentially equivalent amounts of RNA were loaded into 
each  lane. 
cle cells within the myometrium (Fig. 5, A-C) and the walls 
of the spiral arteries (Fig. 5, D-F). Endometrial glandular 
epithelial cells (Fig. 5, G-K) and vascular endothelial cells 
(Fig. 5, D-F) were negative for KGF mRNA under all hor- 
monal conditions. Myometrial fibroblasts were also gener- 
ally negative for KGF mRNA under all hormonal conditions 
(Fig. 5, A-C). 
In animals that were spayed or E2 treated (or in the follic- 
ular phase), stromal cells were negative in all endometrial 
zones (Fig. 5, O and H) except for a few stromal cells closely 
associated with spiral arteries (Fig. 5, D and E). In P-treated 
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Figure  4.  ELISA analysis of KGF  protein  in 
homogenates of  rhesus  monkey endometrium. 
Protein was extracted from the endometrium of 
animals  subjected to  different hormonal  treat- 
ments, and serial dilutions of  each sample were as- 
sayed  along with dilutions of  a recombinant  human 
KGF  standard  as  described  in  Materials  and 
Methods. Each data point was the mean value of 
duplicate measurements. 
(or luteal phase) animals, the stromal cells in the functionalis 
zone appeared negative (Fig. 5 I); however, the stromal cells 
of the basaiis zone showed a definite cytoplasmic signal for 
KGF mRNA (Fig. 5 J). The cellular specificity of the posi- 
tive KGF mRNA signal was even more obvious when the sig- 
nal was enhanced by phase microscopy (Fig. 5 K). During 
P domination, the stromal cells in the perivascular regions 
around the spiral arteries also showed a small increase in the 
level of staining (Fig. 5 F). Sequence specificity was shown 
by the great reduction of signal intensity in competition con- 
trois (Fig. 5 L), excess stringency controls (Fig. 5 M), and 
GFAP probe controls (Fig. 5 N). Positive signals were also 
absent in RNase-pretreated controls (Fig. 5 O). Signals were 
also absent from the smooth muscle cells of the myometrium 
and the walls of the spiral arteries in all of the above control 
preparations (data not shown). 
The in situ hybridization signal was stronger in the smooth 
muscle cells of the myometrium and the spiral arteries than 
in the endometrial stromal cells, even though the signal in 
Northern blots was greater in the total RNA extracted from 
endometrium than myometrium. The reason for this dis- 
crepancy is not clear, but may be related to differences in 
probe penetrability between different cell types. 
P-dependent Glandular and Vascular Proliferation 
In E~-treated and follicular phase animals, there was a sub- 
stantial number of Ki-67-positive cells in the glands of the 
functionalis (Fig. 6 A) and only a minimal number in the 
glands  of the  basalis  (Fig.  6  C).  In  contrast,  in  F_a  + 
Table L  KGF Concentration  in Rhesus Monkey 
Endometrium 
KGF concentration 
Animal number  Hormonal  state  (ng/mg tissue protein) 
11762  ~  + P 14 d  4.0 
14958  F~ + P 14 d  3.5 
11989  Fa + P 14 d  2.1 
14581  Luteal phase  1.1 
9360  Follicular phase  0.26 
11671*  Follicular phase +  F.a  0.12 
"Hormonal state" indicates phase of menstrual cycle or hormone treatment.  14 
d Ea +  P, treated for 14 d with an E,2 implant and then for 14 d with implants 
of Fa  and  progesterone.  * Rhesus  11671  (follicular  phase  +  F-a) was an 
animal injected with 42 #g/kg F-a 28 h before  surgery  during  late follicular 
phase of the menstrual cycle to produce highly elevated levels of ~  to mimic 
the natural preovulatory  Fa surge• 
P-treated and luteal phase animals, glandular proliferation 
was not observed in the functionalis (Fig.  6 B),  but was 
stimulated in the basalis (Fig. 6 D). In addition, the spiral 
arteries proliferated under P influence. During the follicular 
phase (Fig. 6 A), there were few Ki-67 cells in the walls of 
the spiral arteries, while in P-dominated animals (Fig. 6 B), 
there were numerous Ki-67-positive vascular smooth muscle 
cells, perivascular strornal cells, and endothelial cells in the 
spiral arteries. The P-dependent growth of the spiral arteries 
was also evident in GMA sections (Fig. 7, A and B). 
Discussion 
Three different  phases of epithelial proliferation occur in the 
macaque endometrium during the menstrual cycle. The first 
is the repair phase, immediately after menstruation, when 
the  ragged  surface of the  endometrium heals.  This  sur- 
face healing, highly analogous to reepithelialization during 
wound healing, is hormone independent (6). The second oc- 
curs during the follicular phase, in which the glandular epi- 
thelium in the functionalis, but not the basalis, proliferates. 
This proliferation is driven by Ea (27).  Finally, during the 
luteal phase, the basalis glands and the spiral artery system 
proliferate in a P-dependent manner, while the glands of the 
functionalis cease proliferating. The P dependence of this 
burst  of proliferation in  the  basalis  of the  macaque  en- 
dometrium during  the  luW.al phase  has  been  well  docu- 
mented (2, 3, 33, 35). 
Our present findings revealed that KGF mRNA levels were 
dramatically elevated in the endometrium, specifically dur- 
ing the luteal phase in naturally cycling animals or after 
progesterone administration to estrogen-primed spayed ani- 
mals. This rise in KGF expression also was demonstrated by 
measurement of KGF-immunoreactive protein in tissue ex- 
tracts with a two-site ELISA. In situ hybridization showed 
that the P-dependent increase in KGF mRNA expression was 
strongest in the stromal cells located around and between the 
glands of the hasalis. This temporal and spatial correlation 
between KGF mRNA expression and epithelial proliferation 
in  the  basaiis  implies  a  possible  role  for KGF on these 
specific cells as a ~progestomedin; a paracrine factor that 
mediates the actions of progesterone. 
Other potential targets of KGF action in the rhesus mon- 
key are the epithelial cells that form the surface plaque char- 
acteristic of this species (11) during either normal implanta- 
tion or trauma-induced decidualization (17). Ghosh et al. 
Koji et al. Progesterone-dependent KGF mRNA Expression  397 The Journal of Cell Biology, Volume 125,  1994  398 Figure 6. Proliferating cells as indicated  by Ki-67 staining.  Micrographs on the left (A and C) are from an E2-treated animal, and on the 
right (B and D) are from an animal sampled on day 21 of the natural luteal phase (P dominated). Original matmification  in A and B is 
400; bar, 10/an. Original ma~mification in C and D is 160; bar,  12.5/am. (,4) Functionalis,  E2 treated.  Ki-67 staining is evident in many 
slandular epithelial  cells, but is absent from the walls of the adjacent artery.  (B) Functionalis,  P dominated. Ki-67 stainins is absent from 
the glandular epithelial cells, but is evident in many of  the endothelial  (arrows) and smooth muscle cells (arrowheads) of  the spiral arteries. 
(C) Basalis,  E2 treated. A region of the basalis  near the myometrial (My) border,  Ki-67 staining is evident  in some stromal cells but is 
minimal in the glaudular epithelium.  (D) Basalis,  P dominated. A region of the hasalis near the myometrial border.  Ki-67 staining is now 
greatly increased in the glandular epithelium and minimal in the stroma. 
Figure 5. In situ hybridization of  KGF mRNA with dig-labeled eDNA. In the upper three rows of  this figure (includes A-/), the micrographs 
in the left column are from spayed (untreated)  animals,  those in the center column are from Fa-treated  animals,  and those in the right 
colunm are from P-treated  animals.  In the last two rows (includes  J-O), all the micrographs are from P-treated  animals.  All original 
magnifications  were x400. The bar in O represents  10 ttm. (A) Myometrium, spayed. A distinct signal for KGF mRNA is evident in the 
cytoplasm of the smooth muscle cells of the muscle bundles.  The fibroblasts  (Fi) in the connective tissue  separating  the muscle bundles 
are negative.  (B) Myometrium, Fa treated.  The KGF mRNA sjotmal is essentially  identical  to that in the spayed animals,  (C) Myome- 
trium, P treated. The KGF mRNA signal is essentially  identical  to that in the E2-treat~ and spayed animals.  (D) Artery, spayed. A dis- 
tinct signal is evident  in the cytoplasm of the smooth muscle cells that constitute the tunica media of the artery (At). Stromal (St) cells 
lack any significant  signal.  (E) Artery, E2 treated.  The signal evident  in the cytoplasm of the smooth muscle cells of the artery wall is 
about the same strength as in the spayed animals.  A few perivascular stromal cells (arrowheads) show a distinct siotmal. (F) Artery, P treated. 
The signal in the cytoplasm of the smooth muscle cells of the artery wall is about the same as in the E2-treated animals.  Some perivascular 
stromal cells show an increased signal.  (G) Functionalis,  spayed.  The glands (G/) and the periglandular stromal regions are negative for 
KGF mRNA. (H) Functionafis,  E2 treated.  The glands and the periglandular stroma are negative as in the spayed animals.  (I) Function- 
alis,  P treated. The glands and the peri~Jandular  stroma are negative as in the E2-treated animals.  (J) Basalls,  P treated.  The glands are 
negative, but the stroma shows a substantially  increased, distinct signal for KGF mRNA. (K) Basalis,  P treated. This is a phase micrograph 
of the identical section as in J. The signal in the stroma is enhanced, while the glands remain negative.  (L) Basalis,  P treated, competition 
control. Competition with e0~cess unlabeled probe greatly suppresses  the stromal signal.  (M) Basalis,  P treated. Excess stringency control. 
Washing at excessively high stringency removes the signal from the stromal cells. (N) Basalis, P treated.  GFAP probe control. Hybridization 
with GFAP eDNA probe produces no signal in stromal cells.  (O) Basalis,  P treated.  RNase pretreated  control. Treatment  with RNase 
before hybridization with the KGF eDNA probe eliminates  the signal  in the stromal cells. 
Koji et al. Progesterone-dependent  gGF mRNA Expression  399 Figure 7.  GMA sections to illustrate histology of spiral arteries.  A, E2-treated; B, P-treated.  xl00; bar, 20/~m.  (A) Functionalis,  E2 
treated. The perimeter of  a spiral artery in a GMA section is indicated with a dashed line. (B) Functionalis, P treated. The dramatic increase 
in the spiral arteries under P influence is indicated by the increase in the perimeter  outlined by the dashed line. 
(16)  recently  showed that this response was P  dependent, 
since RU 486 could significantly  inhibit  plaque formation 
during experimental decidualization.  Because the fetal tro- 
phoblast and the epithelial cells in zones I and II that form 
the plaque lack progesterone receptors (7, 22, 34), it is likely 
that only those cells that retain their progesterone receptors 
during the luteal phase,  such as stromal cells, spiral artery 
wall cells, and glandular basalis cells (7, 22, 34), could play 
a role in plaque formation. Of note, in situ hybridization also 
localized KGF transcripts to the smooth muscle cells of the 
spiral arteries. These vessels terminate in a rich vascular bed 
near  the  surface of the  endometrium  where the  epithelial 
plaque forms. Consequently, this region might contain KGF 
released from the spiral vasculature that could promote epi- 
thelial proliferation.  In addition, KGF produced by cells in 
and  around  the  spiral  arteries  could directly enhance  the 
proliferation and/or migration of the embryonic trophoblast, 
which invades and canalizes  the spiral  arteries  during  the 
early stages of implantation  (12). 
Endothelial cells and smooth muscle cells in spiral arter- 
ies, as well as some perivascular  stromal cells, proliferate 
during P domination,  as indicated by positive staining with 
the Ki-67 antibody. KGF does not act as a mitogen in vitro 
for endothelial cells, fibroblasts, or vascular smooth muscle 
cells isolated from other tissues (reference 38 and unpub- 
lished observations). Thus, KGF expression in the spiral ar- 
teries probably does not have a direct impact on the growth 
of  these vessels, unless the components of  these unique arter- 
ies possess a distinctive responsiveness to KGF. 
In primates and many other mammals, oviductal prolifera- 
tion is E2-dependent and occurs only during  the follicular 
phase or during  E2 treatment of spayed animals  (6).  P  an- 
tagonizes  this  effect of E2  (6).  Consequently,  the  lack of 
P-dependent  KGF mRNA  in  this  organ  is physiologically 
consistent with the absence of P effects on growth in this tis- 
sue. P may only upregulate KGF expression in tissues where 
P stimulates the proliferation and perhaps differentiation of 
epithelial cells (8). 
Members of the IGF system may interact with and comple- 
ment the actions of KGF during P domination in the primate 
endometrium.  Together, KGF and IGF-I (or insulin at phar- 
macologic  doses)  stimulated  proliferation  of  BALB/MK 
mouse  epidermal  keratinocytes  in  a  chemically  defined 
medium more effectively than KGF alone (38).  P has been 
shown to increase the levels of several IGF-binding proteins 
(19), and IGF-II mRNA was detected in secretory phase hu- 
man  endometrium  (18).  Thus,  during  P  domination,  in- 
creased  levels  of IGF-binding  proteins,  IGF-H,  and  KGF 
may act in concert,  together with other growth factors,  to 
mediate P  action in the primate endomeUium. 
A high affinity KGF receptor (KGFR) has been identified 
as an alternatively spliced variant of FGFR-2 (oek) with exon 
IIIb in place ofma (4, 28, 29). A recent report indicates that 
KGF and KGFR mRNA are both present in the human en- 
dometrium (36). We also have evidence that the KGFR is ex- 
pressed in the rhesus monkey endometrium (unpublished ob- 
servations).  Studies  on  the  hormonal  control,  regulation, 
and cellular localization of the KGFR are currently under- 
way to directly identify those cells in the uterus that are capa- 
ble of responding to this newly identified progestomedin. 
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